文献速递瓣膜病与结构性心脏病

左侧瓣膜干预后三尖瓣反流进展的发病率、预测因素与结局

Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention.
PubMed 文献 · Heart · 2025-11-12

本研究分析1644例2014至2018年因主动脉或二尖瓣疾病接受手术或经导管治疗、且无重度三尖瓣反流的患者,5年三尖瓣反流进展发生率为12.0%(95%CI 10.5%至13.7%)。基线预测因素包括高龄、女性、房颤、既往起搏器植入及较大的三尖瓣环直径,且三尖瓣反流进展与全因死亡及死亡或心衰住院复合终点风险升高相关。

要点

  • 左侧瓣膜干预后5年三尖瓣反流进展发生率为12.0%。
  • 三尖瓣环直径与反流进展呈线性关系,按体表面积标化可减弱性别差异。
  • 三尖瓣反流进展与全因死亡及死亡或心衰住院风险升高独立相关。

核心结论

  • 左侧瓣膜病矫正术后三尖瓣反流进展常见,并与不良结局相关。
  • 将三尖瓣环直径按体表面积标化可减弱风险评估中的性别差异。
  • 高危患者可能需要考虑降低预防性三尖瓣干预的阈值。

研究设计与样本

  • 研究分析了1644例无重度三尖瓣反流、因主动脉或二尖瓣疾病接受手术或经导管治疗的患者。
  • 患者平均年龄73岁,男性占62%,治疗时间范围为2014至2018年。
  • 三尖瓣反流进展定义为随访超声心动图显示三尖瓣反流分级增加至中度或重度。

主要发现

  • 5年时三尖瓣反流进展发生率为12.0%(95%CI 10.5%至13.7%)。
  • 与三尖瓣反流进展相关的基线因素包括高龄、女性、房颤、既往起搏器植入和较大的三尖瓣环直径。
  • 三尖瓣环直径与三尖瓣反流进展的关系呈线性(HR 1.08;95%CI 1.04至1.11;p<0.001)。
  • 三尖瓣反流进展与全因死亡率升高相关(校正HR 2.77;95%CI 2.16至3.56;p<0.001)。
  • 三尖瓣反流进展与死亡或心衰住院复合终点风险升高相关(校正HR 2.91;95%CI 2.21至3.82;p<0.001)。

临床怎么用

  • 对左侧瓣膜干预后患者应关注三尖瓣反流进展,尤其在高龄、女性、房颤、既往起搏器植入及三尖瓣环直径较大者。
  • 使用体表面积标化三尖瓣环直径可能有助于更一致地评估三尖瓣反流进展风险。
  • 对于高危患者,可考虑降低预防性三尖瓣干预的阈值,但需结合个体情况谨慎决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tricuspid regurgitation (TR) progression following left-sided valvular heart disease (VHD) correction is a critical clinical concern. This study aimed to determine the incidence, predictors and outcomes of TR progression in a contemporary cohort. METHODS: We analysed 1644 patients (mean age 73 years, 62% men) without severe TR who underwent surgical or transcatheter treatment for aortic or mitral disease between 2014 and 2018. TR progression was defined as an increase in TR grade to moderate or severe on follow-up echocardiography. RESULTS: At 5 years, TR progression incidence was 12.0% (95% CI 10.5% to 13.7%). Baseline factors associated with TR progression included older age, female sex, atrial fibrillation, prior pacemaker implantation and larger tricuspid annular diameter (TAD). The relationship between TAD and TR progression was linear (HR 1.08; 95% CI 1.04 to 1.11; p<0.001), with sex differences mitigated by indexing TAD to body surface area. TR progression was associated with increased all-cause mortality (adjusted HR 2.77; 95% CI 2.16 to 3.56; p<0.001) and a combined endpoint of death or heart failure hospitalisation (adjusted HR 2.91; 95% CI 2.21 to 3.82; p<0.001). CONCLUSIONS: TR progression is common after left-sided VHD correction and is associated with adverse outcomes. Indexing TAD to body surface area mitigates sex differences in risk assessment. These findings suggest that lower thresholds for prophylactic tricuspid intervention may be warranted in high-risk patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Wang C, Hamid N, Bapat V, et al. Incidence, predictors and outcomes of tricuspid regurgitation progression after left-sided valvular intervention. Heart. 2025. PMID: 40312105. doi:10.1136/heartjnl-2024-325194

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。